Confound-aware lncRNA genomics: Separating biology from abundance, composition, and temporal artefacts

Long non-coding RNAs (lncRNAs) are nominated at scale as disease biomarkers and as targets for antisense and RNA-targeting therapeutics, yet many fail to replicate - a translational liability: an artefactual target wastes preclinical investment. The reflex explanation is that lncRNA biology is intrinsically hard to measure. This Review argues instead that a large, addressable fraction of the irreproducibility is the signature of three pervasive measurement confounds: low transcript abundance, cell-type composition shifts, and steady-state snapshotting. Abundance is the most recurrent axis across them, but not a universal root cause: composition is causally distinct, driven by cell-type restriction, and snapshotting is a separate identifiability problem. Drawing on the primary literature, I show how apparent class-specific phenomena (noisier half-lives, inflated network centrality, detection deficits) largely dissolve once transcripts are compared at matched abundance, and how composition shifts can manufacture, invert or mask a bulk disease association independently of within-cell regulation. All three are preceded by a transcript-definition problem: lncRNA isoforms can carry opposing functions, and roughly half of lncRNAs are estimated to lack a poly(A) tail, so isoform identity and library chemistry determine what is measured at all. I then distil a portable, confound-aware workflow - a transcript-definition step followed by four analytical gates: abundance-matched nulls, composition adjustment, reliability and leakage flags, and orthogonal or temporal validation - and map it onto the biotechnology pipeline as a low-cost risk-reduction filter for biomarker discovery, drug-target selection, diagnostic design and predictive modelling. Trustworthy measurement is the foundation on which trustworthy lncRNA biotechnology is built.